In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
207 News Items found
Memorial Sloan Kettering Alvin Goh, an expert in robotic surgery.
In the Clinic
Robotic Bladder Removal & Reconstruction Surgery

MSK has expanded its bladder cancer surgery options with new robotic methods for constructing a substitute bladder.
Pattie Fuller smiles while wearing a pink plaid poncho
New Treatment for Metastatic (Stage 4) Melanoma: TIL Immunotherapy  

After immunotherapy and targeted therapy failed to bring a patient's melanoma under control, MSK doctors offered her a new treatment called tumor-infiltrating lymphocyte, or TIL, therapy.
(From left) David Scheinberg, Andrew Zelenetz, and Joseph Jurcic are using monoclonal antibodies to improve the treatment of patients with leukemia and lymphoma.
Monoclonal Antibody Drugs for Cancer Treatment

Therapies designed to target cancer while sparing healthy tissue show benefit, but have not yet reached full potential.
MSK's Wungki Park, MD, seen smiling in laboratory.
First-in-Class Investigational Drug KRAS G12D Degrader Shows Promise in Lung and Pancreatic Cancers

Learn how a novel drug is showing promise against lung and pancreatic cancer in early clinical trials by targeting the KRAS G12D mutation with a KRAS degrader.
Amy Speck
Feature
Robotic Neurosurgery at MSK Speeds Recovery From Some Spinal Tumors

MSK surgeons have regularly used robotic surgery since 2007 to remove certain tumors in the chest and abdominal cavity. Now they are using robotic surgery to remove noncancerous tumors of the spine.
Zsofia Stadler presents at the ASCO meeting
Finding
Genomic Marker Is Associated with Lynch Syndrome, a Hereditary Cancer Condition, Across Many Different Cancers

Tumors with a biomarker called high microsatellite instability have been linked to inherited cancer mutations.
Andy Minn and Michael Glickman
Tackling Immunotherapy’s Big Challenges

Learn why immuno-oncology — which seeks to rally and strengthen the immune system’s ability to fight cancer — is the world’s next frontier in cancer research, and how MSK is overcoming some of the field's biggest challenges.
Does Exercise Improve Survival After a Cancer Diagnosis? An Encouraging New Study

Learn how exercise can help many people live longer after they are diagnosed with cancer, according to a new study from MSK's Exercise-Oncology Service.
doctor and patients
In the Clinic
How a Watch-and-Wait Approach May Help People with Rectal Cancer Preserve Their Quality of Life

Discover how a watch-and-wait approach to treating rectal cancer can help people avoid surgery and preserve normal body functions.
Dr. Karuna Ganesh and Elizabeth Benitez in the lab.
How a Better Understanding of Metastasis May Lead to Better Cancer Treatment

Metastasis is responsible for about 9 of every 10 cancer deaths, and it remains one of the most daunting and least understood aspects of the disease. Researchers across MSK are approaching a wide variety of metastatic cancer types from many directions.